// App-Quantinova.ai

e16020 : Final results from a trial of a combination herbal supplement for biochemically recurrent prostate cancer.

Researchers

Presenter

  • Tanya B Dorff

Principal Investigators

  • Denice D Tsao-Wei

  • Debra Hawes

  • Shigang Xiong

  • David I. Quinn

  • Mitchell E. Gross

  • Gary Lieskovsky

  • Nicholas J. Vogelzang

  • Susan G. Groshen

  • Jacek K. Pinski

Medical Centers

  • US Oncology Research/Comprehensive Cancer Centers NV, Las Vegas, NV

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • USC Norris Comprehensive Cancer Center, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00669656

Sponsors

  • N/A

Result

  • N/A